首页> 外文期刊>Ophthalmology >Endoscopic-guided trephination dacryocystorhinostomy (Hesham DCR): technique and pilot trial.
【24h】

Endoscopic-guided trephination dacryocystorhinostomy (Hesham DCR): technique and pilot trial.

机译:内窥镜引导的泪囊泪囊造口术(Hesham DCR):技术和先导试验。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: (1) Test the feasibility and the safety of guided transnasal trephination in creating a nasolacrimal fistula. (2) Develop an appropriate lacrimal maintainer and test its value in modulating healing at the fistula site. DESIGN: Prospective, noncomparative interventional case series. PARTICIPANTS: Five cadavers and 19 patients. METHOD: A transcanalicular lacrimal probe penetrated the lacrimal fossa to guide the passage of a flexible trephine up the nose, which created the nasolacrimal communication. A special wide-caliber lacrimal maintainer was inserted along lacrimal tubes within the created passage. OUTCOME MEASURES: For cadaveric study, direct inspection after dissection of the facial flap was performed. For the clinical trial, subjective improvement in watery eye, dye testing, lacrimal probing, lacrimal irrigation, and endoscopic nasal examination. RESULTS: The technique resulted in the creation of a regular fistula of reproducible diameter into which a standard-shaped wide caliber maintainer could be inserted. Three months after removal of the maintainer and 6 months after surgery, a patent ostium was achieved in 17 of 18 (94%) patients who had a completed procedure. Relief of symptoms was achieved in 83%. CONCLUSIONS: Guided endoscopic dacryocystorhinostomy provides a simple and safe option for the treatment of nasolacrimal duct obstruction. The lacrimal maintainer is a useful device to achieve a large patent nasolacrimal communication.
机译:目的:(1)测试经鼻经鼻环凝治疗产生鼻泪瘘的可行性和安全性。 (2)开发合适的泪道保持器并测试其在调节瘘管部位愈合中的价值。设计:前瞻性,非比较性介入病例系列。参与者:5名尸体和19名患者。方法:经泪小管的泪腺探针穿透泪窝,引导挠性曲啡通过鼻孔,从而形成鼻泪道。将特殊的宽口径泪道保持器沿泪道插入所创建的通道内。观察指标:对于尸体研究,在切开面部皮瓣后进行直接检查。对于临床试验,主观改善水眼,染料测试,泪道探查,泪道冲洗和内窥镜鼻腔检查。结果:该技术导致可再现直径的常规瘘管形成,可将标准形状的宽口径保持器插入其中。拆下保持器三个月后和手术后六个月,在完成手术的18位患者中,有17位(94%)获得了专利的开口。症状缓解率达到83%。结论:引导性内镜下泪囊鼻腔吻合术为鼻泪管阻塞提供了一种简单而安全的选择。泪道维持器是实现大型鼻泪道专利交流的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号